about
Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionRegulatory B cells: an exciting target for future therapeutics in transplantationThe Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ TransplantationElevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejectionDifferential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsInvolvement of NLRP3 inflammasome in rituximab-induced interstitial lung disease: a case report.Prolongation of Cardiac Allograft Survival by Endometrial Regenerative Cells: Focusing on B-Cell ResponsesDiagnosis and management of antibody-mediated rejection: current status and novel approaches.IFN-γ production by memory helper T cells is required for CD40-independent alloantibody responses.Clinical impact of H-Y alloimmunityTolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.Current progress in ABO-incompatible kidney transplantationRational clinical trial design for antibody mediated renal allograft injury.The paradoxical functions of B cells and antibodies in transplantationEffects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques.The Emerging Role of Interleukin-21 in Transplantation.Regulatory B cells and tolerance in transplantation: from animal models to human.The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.Update on the role of rituximab in kidney diseases and transplant.Lymphodepletion and homeostatic proliferation: implications for transplantation.Incompatible kidney transplantation: a brief overview of the past, present and future.B-cell regulation and its application to transplantation.Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.Advances in pharmacotherapy to treat kidney transplant rejection.Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.Comparative In Vitro Immune Stimulation Analysis of Primary Human B Cells and B Cell Lines.Inhibition of B-cell activation and antibody production by triggering inhibitory signals via the PD-1/PD-ligand pathway.Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects.T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow.Rituximab use in late antibody-mediated rejectionAnesthetic management in ABO incompatible kidney transplant.Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.Individualized immunosuppression in transplant patients: potential role of pharmacogenetics.IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.B cells and kidney transplantation: beyond antibodies.Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis.
P2860
Q26738329-E70E741E-2596-483F-B2A8-7786CCB600C4Q27015093-310D8F75-10C7-4E26-87E4-0B60497649C8Q28078919-36122F06-CA7F-468D-80FC-76F229D3900EQ28294329-8B66E7B9-5825-4695-8114-9BF0CB241B23Q30279164-7CDB44CC-59B9-49E9-966E-EAB525BB265FQ33417132-2BBC99AB-E374-409B-8957-3D7C5BB120F3Q33722343-3E81C6C6-0FCC-4DED-AD31-6A0286948ECEQ34841849-A845313B-DB68-4850-8F51-1330A48EAFA6Q34980154-C19483CD-4A8D-49E8-B52D-B7D055D46A75Q35235186-8076AA30-575D-4FC6-BDD5-B197A0713374Q36104784-298C4204-87EF-4E05-B028-428CF4281871Q36134073-A7E1DFD5-76F1-4292-A103-725A759C74D8Q36171175-F0060150-ACF4-49D0-9589-474CF6E831C9Q36173541-F2AB6DB0-C6ED-474B-B423-8274EF1765D4Q36563918-1F30C632-182A-481D-BA02-9BD050B55965Q36888486-0D07E010-486C-4B2A-83E0-24CFFBE2AE94Q36975554-F6443DC6-B0ED-49E5-B921-5513C9D3DF11Q37420774-1AE0DC9A-5CBC-43BC-9CB0-0DB553B07900Q37704938-EA36A0D0-7F9F-4D39-853B-0D2FFA92389FQ37970443-C0BEB5E4-EED5-4E8A-9BEC-B4D8749F0CB5Q37993873-56B8A503-EFF6-405F-915B-68AD0C4801D8Q38036246-25E4AFB8-EA42-4FC9-A1DD-3D6081431935Q38126085-6387A6CF-53FE-4977-9514-8FF5F70F24FEQ38215262-81D9638D-1C68-4721-A6CC-F63D7515FF01Q38544529-AA21F9EA-7E6D-4B0B-A016-0B8AE634A1CEQ38674466-68616533-3C9E-4417-8F33-9027FB29228DQ38719791-8D4B76E2-9813-468F-8BF8-577C1B8192DCQ38747148-2B095DFC-4633-4C09-AE29-5838D5D959BEQ38754057-0E01F623-66EB-47B1-9331-4E05F3F624D3Q38918124-2F34DAC0-4CAA-4CF7-AC1A-304C382286A3Q38995172-8B4CD819-48C2-40FB-BFA6-AC3AED85DD5DQ40321710-071B73B8-7A17-4006-97A1-28D22EDF1063Q41041729-B2692D41-3349-49F6-8375-F0250A13F480Q41055116-D8E2E7BE-CD93-4A62-A0B3-B12F58385F11Q41107298-165CBB1F-449B-4EE7-9E69-6AFD8E6DC418Q42065624-CC276757-B177-4BBE-BBAE-513C4F60BE8CQ42364236-39457ED5-722D-40D4-9B51-E060CC8DAC02Q42712428-2D9E4BEE-0E14-4993-80FA-DE7621978D4FQ44911053-0F0CA557-7206-40CC-8091-054CE27020B5Q45387964-AC01B3A7-A691-47E6-9111-5ABF12EDD6A7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting B cells and antibody in transplantation
@en
Targeting B cells and antibody in transplantation.
@nl
type
label
Targeting B cells and antibody in transplantation
@en
Targeting B cells and antibody in transplantation.
@nl
prefLabel
Targeting B cells and antibody in transplantation
@en
Targeting B cells and antibody in transplantation.
@nl
P2860
P1476
Targeting B cells and antibody in transplantation
@en
P2093
M R Clatworthy
P2860
P304
P356
10.1111/J.1600-6143.2011.03554.X
P407
P577
2011-06-10T00:00:00Z